Objective: It is unknown whether avoidance of cardiopulmonary bypass during coronary artery bypass grafting affects cerebral injury or long-term neuropsychological function.
In an effort to avoid morbidity attributed to cardiopulmonary bypass (CPB), aortic cannulation/clamping, hypothermic cardioplegic arrest, and systemic hemodilution, off-pump coronary artery bypass (OPCAB) techniques were refined and popularized in the 1990s.
1,2 Despite reports of improved outcomes with OPCAB from numerous centers 3, 4 and from the Society of Thoracic Surgeons (STS) National Cardiac Database 5 and the US Veterans Administration database, 6 adoption of OPCAB plateaued at approximately 20% in 2004 and has not changed significantly since that time. 7 This might be due in part to the technically challenging nature of OPCAB and in part due to the lack of compelling reductions in major adverse cardiac events (death, stroke, and myocardial infarction) among the low-risk patients enrolled in small, underpowered randomized controlled trials comparing OPCAB with conventional CABG techniques. 8, 9 One of the strong motivations to explore and adopt OPCAB techniques has been the hope that avoidance of CPB and reduced aortic manipulation would be associated with reduced risk of perioperative stroke and neurocognitive decline associated with coronary artery bypass surgery. 10 Typically enrolling low-risk patients, randomized trials to date have been underpowered to detect a difference in perioperative stroke, an infrequently occurring end point. 9, [11] [12] [13] [14] [15] Nonetheless, risk-adjusted retrospective reviews of numerous large clinical databases have repeatedly demonstrated a clinically and statistically significant reduction in perioperative stroke for patients undergoing OPCAB compared with conventional CABG during CPB. 5, 6, 16, 17 The early studies among these patients were legitimately criticized because of their inability to account for intraoperative conversion of patients from OPCAB to CPB to report an intent-to-treat comparison. This potential source of bias was addressed by the introduction of a data field in the STS National Cardiac Database to report intraoperative conversion and subsequently by the first intent-to-treat analysis of the STS database, which confirmed an adjusted odds ratio for stroke in patients undergoing OPCAB of 0.65 (P<.001). 16 Although it seems logical that elimination of CPB and reduction in aortic manipulation should reduce the risk of embolic and ischemic stroke, 18 it must also be acknowledged that the specific technique for performing (or avoiding) proximal anastomoses on the ascending aorta (including single, double, or no aortic clamp) can have a significant effect on stroke risk, especially in patients with atherosclerosis of the ascending aorta, independent of the use or avoidance of CPB during surgical coronary revascularization. 19 Whether CABG causes neurocognitive decline [20] [21] [22] is contested, and several studies have reported similar change from baseline neurocognitive function in risk-matched 23 or randomized 24 patients undergoing CABG versus percutaneous coronary intervention or CABG versus noncardiac surgical procedures. 25 Measures of neurocognitive or neuropsychological function are inherently imprecise and prone to a variety of systemic biases and confounders. Moreover, there is no general agreement on which of the many available tests are most appropriate, 26 what would constitute a clinically significant decline, 27 or even how to best perform statistical comparisons of test scores across multiple neuropsychological domains. 28 Perhaps as a result of this methodological imprecision, single-center prospective studies have reported ''significant'' decline relative to that seen in control subjects in neuropsychological performance ranging from zero percent 23 to 53% 20 of patients after conventional CABG during CPB.
Magnetic resonance imaging (MRI), especially with diffusion-weighted techniques, has been the preferred imaging modality to demonstrate acute cerebral emboli. Nonetheless, the resolution of presently available scanners is such that defects smaller than 1 mm are not detectable. Moreover, the correlation between detection of new brain lesions on MRI scanning and the appearance of new decline in neurocognitive function has been disappointingly weak in at least 1 previous small clinical series. 29 The Surgical Management of Arterial Revascularization Therapies (SMART) trial was conceived to rigorously compare completeness of revascularization, clinical outcomes, and resource use in unselected patients referred for elective primary CABG randomly assigned to undergo OPCAB or conventional CABG during CPB. Similar graft patency was demonstrated between groups by means of coronary angiographic analysis before hospital discharge and at the 1-year follow-up and by means of computed tomographic angiographic analysis at a mean of 7.5 years of followup. 13, 30, 31 The principal secondary end points of the SMART trial were neuroanatomic and neurocognitive outcomes, as measured by using early and late diffusionweighted brain MRI and neuropsychological testing at late follow-up. These results are the subject of this report.
MATERIALS AND METHODS
Between March 2000 and August 2001, 297 unselected patients with multivessel coronary artery disease were approached for voluntary enrollment in the SMART trial. Two hundred of these 297 patients were randomly assigned to undergo off-pump or on-pump coronary artery bypass grafting by a single surgeon (J.D.P.). A single crossclamp was used in the CPB group; partial occlusion clamping of the ascending aorta was used for proximal anastomoses in the OPCAB group, when intraoperative epiaortic ultrasound scanning of the ascending aorta revealed less than grade 3 atherosclerosis. The sample size for the SMART trial was chosen for the ability to detect a 5% absolute difference between groups in the primary end point of graft patency.
After a mean of 7.5 years (range, 6.8-8.4 years), 87 of the original participants volunteered to return for late follow-up. As of March 30, 2009 , there were 26 deaths from all causes among patients undergoing OPCAB and 31 among patients undergoing CPB since initial enrollment. Reasons for loss of patients to follow-up are listed in the consort flow diagram (Figure 1 ).
Neuropsychological Testing
Of the 87patients who returned for late follow-up, 76 (41 undergoing CPB and 35 undergoing OPCAB) underwent a focused battery of neuropsychological tests to determine whether the surgical groups differed with respect to cognitive function. The trained and certified neuropsychological test administrators were blinded to treatment assignment. 
Brain MRI Scanning and Image Interpretation
Early MRI of the brain was performed during the index hospitalization on a Philips Gyroscan ACS-NT 1.5 T scanner. Late MRI images at longterm follow-up were acquired on a GE Healthcare Signa HDx 1.5T MR scanner. The axial T1-weighted, axial T2-weighted, axial fluid attenuated inversion recovery (FLAIR), and axial diffusion-weighted images were interpreted by a board-certified neuroradiologist.
Cerebral white matter lesions are identified by areas of abnormal hyperintensity in the T2-weighted or FLAIR images, which represent parenchymal injury of predominately indeterminate acuity or chronicity. These lesions are nonspecific and can be secondary to almost any pathologic process, including ischemia, inflammation, infection, or neoplasm. Given the relatively advanced age of the patients enrolled in this study, these lesions most likely represent chronic microvascular ischemic changes, which tend to increase in prevalence with age and are associated with common cardiovascular risk factors, such as hypertension. Diffusion abnormalities, defined as areas of restricted diffusion, are also nonspecific but most commonly associated with acute or subacute infarction.
White matter lesions and areas of diffusion abnormalities were interpreted according to a scoring system modified from the work by Scheltens and colleagues 32 :
1. Temporal lobe atrophy and frontal lobe atrophy were each subjectively graded on a scale from 0 (normal) to 4 (severe). 2. Hyperintense white matter lesions in either the T2-weighted or FLAIR images were graded from 0 (normal) to 6 (severe), according to the ordinal scale shown in Table 2 . 3. Lesions with diffusion abnormality (acute or subacute infarctions) were graded by using the same scale.
The late follow-up MRI images were scored by using the same scales and supplemented with an additional score for periventricular lesions. For purposes of scoring, periventricular lesions were defined as those in contact with the ventricles. The thickness of the lesions was measured along the lateral ventricles. Three separate scores were given for lesions adjacent to the frontal horns of the lateral ventricles (anterior), adjacent to the bodies (mid), and adjacent to the trigones (posterior; Table 3 ).
An additional quantitative image analysis was performed to compute regional cerebrospinal fluid (CSF) volumes to quantitatively assess brain parenchymal volume loss (atrophy). The images of the multiple pulse sequences were spatially registered with each other, and a region of interest (ROI) was manually drawn in the white matter of the corpus callosum The largest lesion measures between 4 and 10 mm <6 4
The largest lesion measures between 4 and 10 mm !6 5
At least 1 lesion is >10 mm 6
Severe confluent parenchymal signal abnormality or transcortical territorial infarction is present (splenium, genu, or both) of each patient. Each image was then normalized with the average white matter intensity computed from the ROI. Other ROIs were drawn in the gray matter (thalamus) and CSF (lateral ventricles) to obtain characteristic signal intensities. The ''distance'' d for each voxel was then computed relative to the characteristic signal intensities. Analogous equations defined the distances for gray matter (d GM ) and white matter (d WM ). Segmented images were manually checked and corrected, such as excluding the voxels representing fluid in the orbital globes. The volume of CSF was then computed in groups of compartments corresponding to the anterior frontal, frontal periventricular, anterolateral temporal, medial temporal, perisylvian, and peritrigonal regions of the brain in a manner similar to the work by Arimura et al 33 ( Figure 2 ). Brain MRI scans were scored on ordinal scales with respect to diffusionweighted lesions, T2, temporal lobe atrophy, and frontal lobe atrophy. Comparisons of OPCAB versus CABG during CPB with respect to these scales were made for both early MRI studies (n ¼ 83 and n ¼ 85, respectively) and late follow-up MRI (n ¼ 35 and n ¼ 32, respectively). Furthermore, for patients who had scans at both time points (n ¼ 27 and n ¼ 32, respectively), the change in ordinal status was compared across groups to see whether one group experienced statistically different changes over time. All analyses of ordinal scales were made by using nonparametric Wilcoxon tests.
The correlations between the neuropsychological test results and the MRI findings were estimated by using the Spearman rank coefficient (the nonparametric statistic was used because of the ordinal nature of the MRI measurements). The previously described neuropsychological test results were analyzed for correlation with MRI findings at both baseline and up to the 8-year follow-up. For patients who had MRI performed at both time points, the neuroanatomic changes from baseline to follow-up were correlated with neuropsychological test results. Furthermore, neuropsychological test results were examined for correlation with CSF volumes measured in 6 brain regions: anterior frontal lobes, frontal periventricular, anterolateral temporal, medial temporal, perisylvian, and peritrigonal.
Statistical Analysis
To address concerns about selection bias in the present follow-up study, c 2 and t tests were performed to determine whether the means of clinical risk factors of the returning group of SMART patients (1) differed according to their original type of operation (OPCAB or conventional CABG) and (2) differed from the original cohort in general. Furthermore, common confounders of cognitive effects, including age, sex, and IQ, were examined for differences across groups. All analyses were performed with SAS Version 9.2 software (SAS Institute, Inc, Cary, NC). All tests were evaluated at the .05 significance level. No adjustments for multiple tests were performed.
RESULTS
Among the 41 patients undergoing CPB and 35 patients undergoing OPCAB tested for cognitive function, the mean age was 66.7 years (range, 38-90 years). Patients undergoing OPCAB (mean, 64.9 years; range, 38-90 years) were younger than patients undergoing CPB (mean, 68.3 years; range, 52-89 years), but the difference was not statistically different (P ¼ .14). Nine (22.0%) patients undergoing CPB and 8 (22.9%) patients undergoing OPCAB were female (P ¼ .92). The groups were also similar with respect to all preoperative clinical characteristics ( Table 4 ). The patients who returned for follow-up were not significantly different either between groups at follow-up or compared with the original groups at the time of randomization. Furthermore, on full-scale testing, IQ was found to be statistically similar between the CPB and OPCAB groups (96.2 vs 101.4, P ¼ .21). Table 5 summarizes the analyses of the neuropsychological test results, which were performed only once, at a mean of 7.5 years of follow-up. Statistically significant differences between groups were seen primarily on tests of executive function. Although the magnitudes of the differences are small, patients undergoing OPCAB obtained higher scores on Spatial Span Backward and made fewer errors on the Short Category Test. Patients undergoing OPCAB also tended to remember more items from the RAVLT by the final learning trial, although the difference between groups was not statistically significant. A comparison of neuropsychological function after OPCAB versus CPB among diabetic patients is presented in Table 6 . In all 13 neuropsychological tests the mean performance score for patients with OPCAB was superior to that of patients with CPB. Perhaps because of the small diabetic sample size at follow-up (10 patients undergoing OPCAB vs 17 patients undergoing CPB), none of these individual test scores were statistically significant. Table 7 , shows the findings of early MRI among 168 patients and late MRI among 67 patients. Early MRI in 168 patients showed no significant differences between surgical treatment groups in atrophy, subcortical white matter lesions, or acute infarctions. Among 59 patients who had both early and late MRI, there were no significant differences between surgical treatment groups with respect to atrophy over time or new subcortical white matter lesions or infarctions. Interestingly, there were significantly more diffusion-weighted abnormalities in subcortical white matter (new cerebral infarctions) among patients with diabetes than among patients without diabetes in both surgical treatment groups (Table 8) early after surgical intervention. Moreover, although baseline atrophy scores were similar for diabetic and nondiabetic patients early after surgical intervention, there was significantly greater cerebral atrophy at follow-up and a significantly greater increase in atrophy between baseline and follow-up among diabetic patients than among nondiabetic patients. However, there were statistically similar numbers of new diffusion-weighted abnormalities in subcortical white matter among diabetic patients who had CPB and those who had OPCAB. Atrophy over 7.5 years of follow-up was also similar for diabetic patients who had CPB and those who had OPCAB ( Table 9 ). The first 4 rows of Table 10 show the correlation between baseline (early) brain MRI and neuropsychological test result at late follow-up. Correlational analyses were done specifically on neuropsychological tests for which a statistically significant difference (or trend toward a significant difference) in scores was found between the CPB and OP-CAB groups. At baseline, these findings indicate that patients with greater degrees of frontal atrophy performed less well on the Wechsler Memory Scale Spatial Span Backwards score (r ¼À0.29, P ¼ .024) and the number of Short Category Test errors (r ¼ 0.32, P ¼ .012), again indicating that impaired cognitive test performance is associated with cerebral atrophy.
The middle 4 rows of Table 10 show correlation between brain MRI images at late follow-up and neuropsychological test results at late follow-up. At follow-up, significant associations were seen between temporal lobe atrophy and both the Wechsler Memory Score (r ¼À0.27, P ¼ .041) and the RAVLT-5 (r ¼ À0.30, P ¼ .021), indicating that increased atrophy does indeed result in diminished cognitive abilities. Similarly, frontal lobe atrophy was significantly related to the Wechsler Memory Score (r ¼ À0.41, P ¼ .002) and the number of Short Category Test errors (r ¼ 0.32, P ¼ .012), again indicating that cognitive abilities are affected by atrophy.
The last 4 rows of Table 10 show correlation between changes in brain MRI findings from early baseline to late follow-up with neuropsychological testing at late followup. The change in brain atrophy from baseline to followup was not associated with any neuropsychological test findings in this limited patient sample.
Of note is the finding that the surgical groups did not differ with respect to measures of CSF volumes, which serve as a more quantitative measure of cerebral atrophy. Moreover, the 2 different measures of cerebral atrophy used in the present study (ie, ordinal scale estimates and quantitative CSF assessment) correlated highly with each other and correlated similarly with neuropsychological outcomes. There were (Table 11) .
DISCUSSION
The present prospective randomized trial is the largest US trial of OPCAB with angiographic graft assessment and longer-term follow-up of neuroanatomic and neuropsychological outcomes. Survivors voluntarily returned at a mean of 7.5 years for formal neuropsychological testing and brain MRI. Of 200 patients initially randomized, 76 (41 undergoing CPB and 35 undergoing OPCAB) had neuropsychological testing at late follow-up. Groups were similar with respect to potential confounders, such as age, sex, depression, and IQ, both at enrollment and at long-term follow-up.
At late follow-up, patients undergoing OPCAB showed better attention, performing better at simultaneously tracking and mentally manipulating visual information (P ¼ .011). Patients undergoing OPCAB showed a trend toward better verbal learning (P ¼ .064). There were no significant differences between groups in visuospatial memory. Patients undergoing OPCAB showed better cognitive reasoning, making fewer errors in reasoning (P ¼ .05). There were no domains in which patients undergoing CPB outperformed All numeric values are means of ordinal scales within each surgical group. MRI, Magnetic resonance imaging; DWI, diffusion-weighted abnormalities in subcortical white matter; T2, T2-weighted or fluid attenuated inversion recovery signal abnormalities in subcortical white matter; Frontal atrophy, atrophic changes in frontal lobe (subjective ordinal scale); Temporal atrophy, atrophic changes in temporal lobe (subjective ordinal scale); Perivent frontal, thickness of lesions present in the periventricular white matter adjacent to the frontal horns; Perivent posterior, thickness of lesions present in the periventricular white matter adjacent to the posterior trigones; Perivent lateral, thickness of lesions present in the periventricular white matter adjacent to the mid-lateral portion of the ventricles.
those undergoing OPCAB. These results overall suggest that patients undergoing OPCAB had better preserved executive function. However, these differences were relatively small, in the range of 12% to 15%, and none met the benchmark of a 20% difference, which is frequently considered in the literature to be clinically significant. 27, 34 A strong relative benefit of off-pump techniques over conventional CABG during CPB with respect to neurocognitive outcomes has been reported in several single-center prospective trials. Among 40 randomized patients, Diegeler and associates 35 reported that emboli detected in the middle cerebral artery during OPCAB were fewer than during conventional CABG; postoperative serum levels of the neurobiochemical marker protein S-100 were correspondingly lower and neurocognitive function better in patients randomized to OPCAB than to conventional CABG during CPB. Zamvar and colleagues 36 randomized 60 patients and reported neurocognitive impairment at 1 week postoperatively in 27% of patients undergoing OPCAB and 63% of patients undergoing CPB; at 10 weeks postoperatively, 10% of patients undergoing OPCAB and 40% of patients undergoing CPB showed impairment during neurocognitive testing.
Van Dijk and coworkers 37 randomized 281 patients to OPCAB versus CPB and reported improved cognitive outcomes 3 months after the procedure, but these effects were small and became negligible at 12 months. Al-Ruzzeh and associates 38 randomized 168 patients and found those who underwent OPCAB showed better neurocognitive function at 6 weeks and 6 months postoperatively compared with those who underwent CABG during CPB.
However, the subset of 120 randomized patients in the Best Bypass Surgery trial who had neuropsychological testing preoperatively and postoperatively did not demonstrate any significant difference in the incidence of cognitive dysfunction 3 months after either OPCAB or CPB. 39 Similarly, 201 patients randomized by Hernandez and colleagues 40 to have OPCAB versus CPB demonstrated no significant difference in the incidence of neurocognitive deficits 6 months after surgical intervention. Lund and coworkers 41 reported a large, statistically significant difference between OPCAB and CPB in cerebral microemboli detected by means of transcranial Doppler ultrasonographic analysis among 120 randomized patients but no significant difference in neuropsychological performance between groups nor any correlation between the number of cerebral microemboli and the degree of neurocognitive dysfunction. Similarly, Liu and associates 42 compared intraoperative cerebral microemboli and neuropsychological function between matched cohorts undergoing OPCAB versus CPB and found that MRI, Magnetic resonance imaging; CPB, cardiopulmonary bypass; OPCAB, off-pump coronary artery bypass; DWI, diffusion-weighted abnormalities in subcortical white matter; T2, T2-weighted or fluid attenuated inversion recovery signal abnormalities in subcortical white matter; TT, temporal tip atrophy. NP, Neuropsychological; MRI, magnetic resonance imaging; DWI, diffusion-weighted abnormalities in subcortical white matter; T2, T2-weighted or fluid attenuated inversion recovery signal abnormalities in subcortical white matter; Frontal atrophy, atrophic changes in frontal lobe (subjective ordinal scale); Temporal atrophy, atrophic changes in temporal lobe (subjective ordinal scale).
OPCAB was associated with significantly fewer cerebral microemboli, but similar incidence of neuropsychological dysfunction.
The finding in the present study that neuropsychological function was superior in patients who have had OPCAB versus conventional CABG during CPB is consistent with some previous reports 12, 35, 36 but inconsistent with others. [40] [41] [42] The relatively small sample size and absence of baseline preoperative neuropsychological testing in the present study render these findings additive to the literature rather than conclusive or definitive.
Before discharge from the index surgical hospitalization, diffusion-weighted brain MRI in 168 patients showed no significant differences between groups in atrophy, subcortical white matter lesions, or acute infarctions. Among 59 patients who had brain MRI both at the index hospitalization and at a mean of 7.5 years of follow-up, there were no significant differences between groups with respect to atrophy over time or new subcortical white matter lesions or infarctions. These findings are consistent with those of Lund and colleagues, 29 who reported a similar incidence of new postoperative cerebral lesions in 120 patients randomized to OPCAB versus CPB imaged with brain MRI at 3 months postoperatively.
The present study includes 168 diffusion brain MRI studies early after randomization to OPCAB versus CABG during CPB. This is the largest such dataset extant and, as such, has the opportunity to add meaningfully to our understanding of the effect of CPB on neuroanatomic outcomes in patients undergoing surgical coronary revascularization. Of primary interest is the fact that very few patients had any new cerebral infarctions detectable by means of brain MRI after coronary bypass either with or without CPB. This reflects a paucity of emboli of sufficient size to be detectable by means of currently available MRI imaging. Nonetheless, if the neuropsychological differences observed between surgical groups in the present study and in several previous studies are the result of fewer embolic events after OPCAB than after CABG during CPB, then one must assume that neurocognitive decline might be caused by emboli too small to be detected by means of MRI scanning. Alternatively, there might be other ways in which CPB impairs postoperative cerebral function. Such putative mechanisms might include the systemic inflammatory response, hemodilution, hypothermia, and nonspecific metabolic derangements. Such nonembolic cerebral impairment might be expected to resolve over a period of weeks or months. Indeed, several studies have reported a neurocognitive benefit of OPCAB over CPB early after surgical intervention but no difference at 6 to 12 months. 43, 44 Although diffusion-weighted brain MRI can distinguish between recent cerebral infarctions (around which localized edema is evident) and old cerebral infarctions (which lack edema) but has poor resolution to detect very small emboli and does not image metabolic dysfunction, which might exist after microembolic injury in the absence of detectible cerebral infarction.
More rapid progression of brain atrophy and cognitive decline in nonsurgical patients with diabetes mellitus compared with nondiabetic patients has been previously reported. 45 Moreover, white matter changes predict cognitive decline in elderly nonsurgical patients. 46 The finding in the present study that diabetic patients had significantly more acute perioperative cerebral infarctions by means of brain MRI than nondiabetic patients and worse atrophy at late follow-up after CABG has not been previously reported. It is possible that diabetic vasculopathy in both extracranial and intracerebral vessels predisposes diabetic patients to greater risk of macroemboli and microemboli during cardiac surgery, irrespective of the use or avoidance of CPB. Moreover, the absence of any difference in infarctions or atrophy between surgical treatment groups among diabetic patients might reflect the use of an aortic clamp in both groups. Interestingly, the association of cognitive impairment with brain MRI measures has been equivocal in nonsurgical patient populations as well. 47 
Limitations
The present study has several important limitations, including a small sample size. Despite the absence of any significant difference in the means of the clinical characteristics of the randomized patient groups at baseline, at late follow-up, or within surgical groups compared between baseline and follow-up, the large attrition between enrollment and late follow-up introduces the potential for important selection bias for which no adjustment is possible. The absence of neuropsychological testing before surgical intervention or at early follow-up limits the strength of comparisons between groups over time.
CONCLUSIONS
After a mean of 7.5 years of follow-up in this randomized trial, OPCAB was associated with better performance in some neuropsychological domains compared with CPB, primarily on tests of executive function. These differences are of uncertain clinical significance. Early diffusionweighted brain MRI showed no significant differences in acute cerebral infarctions between the OPCAB and CPB groups but more frequent lesions among diabetic patients in both groups. Temporal and frontal lobe cerebral atrophy demonstrated by early or late MRI scanning correlated with impaired neuropsychological function in both groups. However, repeat MRI at late follow-up showed interval atrophic changes that were worse in patients with diabetes but similar between surgical groups.
Discussion
Dr John W. Hammon, Jr (Winston-Salem, NC). Thank you very much. John, that was an excellent presentation, as usual, and what we have come to expect from you. I personally admire your tenacity in following your early hypothesis that off-pump surgical intervention was superior to on-pump surgical intervention and your attempts to show us why. I think we all appreciate that there are some definite advantages of off-pump surgical intervention. Let's talk about the secondary end points that you reported today.
I think you are particularly to be congratulated on having the largest series of brain MRI studies done early postoperatively in these 2 groups of patients, and I think your disappointment in finding that there are no differences needs to be discussed a little bit further. Therefore my first question is this: If you took high-risk groups of patients for brain infarction after surgical intervention (ie, patients who had previous stroke or perhaps diabetes) and teased those out, did you find any differences in those groups of patients? Dr Puskas. We did look at nondiabetic versus diabetic patients and found no significant difference between off-pump and on-pump surgical intervention in either nondiabetic or diabetic patients.
Dr Hammon. Did you find any differences in the total group between diabetic and nondiabetic patients? Dr Puskas. We did not do that specific P value that I can recall. Dr Hammon. You might want to do that because I would bet that there would be some differences.
The second item of business is neuropsychological studies. You have been very honest and reported the deficiencies in your group, which was small, and the fact that you got statistical significance means something. Therefore what exactly does it mean? By not having a baseline study, it is very difficult to say that the groups were similar. Some of the neuropsychological tests are very significantly affected by the amount of learning that persons have, and I do not remember in reading your abstract or your article that you had entered that variable in the preoperative characteristics. That is something you might want to look at, because particularly in executive function, people who have higher learning do better on those tests.
Nevertheless, it is a very good study and adds immensely to our knowledge of this subject, and I congratulate you.
Dr Puskas. Thank you, Dr Hammon. We did correct for the level of education in our assessment of the neuropsychological outcomes, but undoubtedly, the single greatest deficit of the design of this study, and it is clearly my fault, is that we did not perform preoperative neuropsychological testing 10 years ago or 8½ years ago now. We actually designed the trial initially to do preoperative neuropsychological testing and early postoperative diffusionweighted brain MRI scanning, but we found that the inability to get a PhD neuropsychologist to show up at 6 PM the night before the operation was a show stopper. We could not enroll patients. Therefore we decided that we would jettison that to get the trial done, and therefore after about 2 weeks we gave up; probably my characteristic tenacity failed me at that point. We should have done that, but I cannot go back 8 years.
Dr Lawrence H. Cohn (Boston, Mass). John, let me ask you a question. You might have said this and I apologize for not reading your extensive bibliography, but have you shown in the semiacute phase, such as 3 months or 1 year, imaging differences like you tried to show today? Dr Puskas. The next largest series of brain MRI scans after cardiac surgery was published in 2005 by Lund. He randomized 120 patients to off-pump and on-pump surgical intervention and did a single study, which was a brain MRI, actually a single brain MRI study at 3 months, and he found no difference in diffusionweighted changes at that time or atrophic changes. I think the bottom line is that brain MRI does not have a resolution adequate to detect small emboli or other factors that affect how we think and function cognitively. It is just too blunt a tool.
Dr Hammon. You keep mentioning emboli as the cause of MRI lesions. We have done a number of studies in our laboratory on what causes MRI lesions, and in about half of them, there is no known cause. Therefore I think to refer to them as embolic lesions is probably not correct. I think you need to call them infarcts.
Dr Puskas. Fair enough. I think that is absolutely well taken. That is probably why, John, the several very small studies have failed to demonstrate a correlation between intraoperative, transcranial, Doppler high-intensity transient signals in the middle cerebral artery and subsequent early postoperative, diffusion-weighted MRI scans. That in and of itself is a real paradox unless you accept the fundamental notion that not all cerebral infarcts or microinfarcts are caused by emboli.
Dr Juergen Carl Ennker (Lahr, Germany). Congratulations, Dr Puskas, for this very outstanding study, which again underlines the importance of the OPCAB technique, which is absolutely necessary after the ROOBY study. I have a technical question. I would have expected an even larger benefit for patients undergoing OP-CAB. My question is this: Did you use a no-touch aortic technique in your patients undergoing OPCAB, such as by using T grafts? Dr Puskas. That is a great question. In the year 2000, when we were doing these operations,, we did not have the same attention to avoiding the ascending aorta that we do now. Therefore the large majority of patients in both the off-pump and on-pump groups had some form of clamp on the ascending aorta. You know that the Heartstring and other proximal anastomotic devices were not available in 2000, and therefore the vast majority of patients undergoing off-pump surgery had a partial occlusion clamp on the ascending aorta unless their intraoperative epiaortic ultrasound demonstrated significant ascending aortic atheroma, in which case they had a no-touch technique in both groups.
Dr Carlos A. Mestres (Barcelona, Spain). Dr Puskas, just one last quick thing. Of course you have mentioned the limitations of your work. In your conclusions you said that you found just a ''modest'' superiority. The point is this: Was this what you expected? Of course, this is not science, but give us your gut feeling.
Dr Puskas. There are several studies in the literature that would argue that a clinically significant difference in neuropsychological outcomes requires a 20% change or difference in at least 20% of the domains tested. We had a statistically significant difference in more than 20% of the domains tested, but none of those differences actually reached an absolute 20% decrement or difference between the 2 groups. Of course, what is clinically significant matters differently to different patients: manual dexterity matters more to a violinist and cognitive reasoning matters more to a physicist.
